PSMA-RLT in Biochemically Recurrent PCa
NCT06220188
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer Recurrent
Interventions
DRUG:
[177Lu]Lu-PSMA I&T
Sponsor
Medical University of Vienna